Unknown PHASE4 INTERVENTIONAL 2-arm NCT02301806

Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM

A Randomized, Prospective, Parallel Design Study to Compare the Effectiveness of Sitagliptin Versus Glimepiride on Endothelial Dysfunction During an Oral Glucose Loading in Drug Naive Patients With Type 2 Diabetes.

Sponsor: Dokkyo Medical University

Conditions Type 2 Diabetes

Interventions Glimepiride Sitagliptin dieting

Updated 7 times since 2017 Last updated: Feb 15, 2016 Started: Jan 31, 2015 Primary completion: Jun 30, 2017 Completion: Jul 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02301806, this PHASE4 trial focuses on Type 2 Diabetes and remains ongoing. Sponsored by Dokkyo Medical University, it has been updated 7 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Jun 2022 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2021 — Jun 2022 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 2 earlier versions

Mar 2018 — Jun 2018 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status
Jan 2017 — Mar 2018 [monthly]

Recruiting PHASE4

First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dokkyo Medical University
Merck Sharp & Dohme LLC

Data source: Dokkyo Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mibu, Japan